Efficacy and Safety of DR-103 for the Prevention of Pregnancy

Study Title

A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

Teva Identifier

DR-103-301

ClinicalTrials.gov Identifier

NCT00996580

Study Status

Completed

Trial Condition(s)

Pregnancy Prevention

Interventions

Drug: DR-103

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
female icon for clinical trials

Key Participation Requirements

Gender

Female

Age Range

18 Years to 40 Years

Trial Duration

10/01/2009 - 09/01/2011

Phase

Phase 3

Study Type

Interventional